HTT and Huntington disease: Gellerich et al. conducted research on the mitochondria in the brains of transgenic HD rats with the 51-glutamine repeat (htt 51Q) and found that the mitochondrial toxicity of htt 51Q appears to be affecting the regulatory binding sites of Ca2+-induced mitochondrial carrier proteins, such as Aralar and mPTP.